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STRUCTURED ABSTRACT 
OBJECTIVE: Our study aims at producing acellular extracellular matrix scaffolds from the human 
pancreas (hpaECMs), as a first critical step towards the production of a new generation, fully human-
derived bio-artificial endocrine pancreas (BAEP). In this BAEP, the hardware will be represented by 
hpaECMs, while the software will consist in the cellular compartment generated from patient’s own cells.  
SUMMARY BACKGROUND DATA: ECM-based scaffolds obtained through the decellularization of 
native organs have become the favored platform in the field of complex organ bioengineering. However, 
the paradigm is now switching from the porcine to the human model. 
METHODS: To achieve our goal, human pancreata were decellularized with Triton-based solution and 
thoroughly characterized. Primary endpoints were: complete cell and DNA clearance, preservation of 
ECM components, growth factors (GFs) and stiffness, ability to induce angiogenesis, conservation of the 
framework of the innate vasculature, and immunogenicity. Secondary endpoint was hpaECMs’ ability to 
sustain growth and function of human islet and human primary pancreatic endothelial cells (hPPEC). 
RESULTS: Results show that hpaECMs can be successfully and consistently produced from human 
pancreata, maintain their innate molecular and spatial framework and stiffness, as well as vital GFs. 
Importantly, hpaECMs inhibit human naïve CD4+ T cell expansion in response to polyclonal stimuli by 
inducing their apoptosis and promoting their conversion into regulatory T cells. hpaECMs are 
cytocompatible and supportive of representative pancreatic cell types.  
DISCUSSION: We therefore conclude that hpaECMs has the potential to become an ideal platform for 
investigations aiming at the manufacturing of a regenerative medicine-inspired BAEP.  
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1. Introduction 
Diabetes mellitus [DM] has reached pandemic levels and represents a growing burden both on 
health-care expenditures as well as the quality and quantity of life for afflicted individuals.1-4 Exogenous 
insulin-based intensive glucose control can prevent acute metabolic decompensation and is life-saving in 
type 1 DM [T1DM], but does not completely protect against the long-term. β-cell replacement through 
either islet or pancreas transplantation (PTX) are the only therapies able to reliably re-establish a stable 
euglycemic state, long-term. PTX is indicated for patients with T1DM and some selected cases of type 2 
DM [T2DM], yet it remains underutilized. In fact, in the US, for every 10,000 patients with T1DM, only 
3 will actually receive PTX or islet transplant in their lifetime, due to factors such as the lack of suitable 
pancreas donors, the burden of chronic toxicity determined by lifelong immunosuppression, and other 
issues related to financing and access to transplantation;5 when T2DM is considered, only three patients in 
one million will ever receive PTX or islet transplant. Therefore, the identification of a new, potentially 
inexhaustible source of β-cells for transplantation is extremely urgent. 
Regenerative medicine has shown an immense potential to address the limited number of 
transplantable organs and to allow immunosuppression-free transplantation.6-15 Among the different 
technologies under development, the seeding of cells on supporting scaffolding material (cell-on-scaffold 
seeding technology, CSST)16 appears to offer the quickest route to clinical application.6 This technology 
is based on the striking evidence that extracellular matrix (ECM) proteins and structures play fundamental 
roles in the determination, differentiation, proliferation, survival, polarity, welfare and migration of 
cells.17 So far, CSST has allowed the production of numerous, yet relatively simple organs that were 
eventually implanted in more than 200 patients, for therapeutic purposes.6  As these body parts were 
bioengineered from patient’s own cells, immunosuppression was never needed. CSST is also being 
applied to bioengineer more complex organs for transplant purposes.  At Wake Forest, we have developed 
an innovative method that, through the detergent-based decellularization of porcine and human organs, 
allows successful and consistent production of acellular extracellular matrix (ECM) scaffolds.18-20 
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We envision that when a patient will need beta cell replacement therapy, s/he will be offered a 
new generation bio-artificial endocrine pancreas (BAEP) consisting of a software and a hardware. The 
software will be represented by beta cells generated through the ad hoc differentiation of either progenitor 
cells obtained from the patient’s pancreas, or induced pluripotent cells reprogrammed from patient’s 
fibroblasts. Patient-derived beta cells will be seeded or embedded in the hardware of the BAEP, namely 
the 3D framework of ECM scaffolds produced from pancreata of allogenic human origin. To this end, we 
have tested here our decellularization method to discarded human pancreata and we carefully 
characterized the molecular, physical, and immune properties of human pancreas acellular ECM scaffolds 
(hpaECMs) together with their cytocompatibility. 
 
2. Material & Methods 
2.1 Pancreas and endothelial cell procurement 
Twenty-five human pancreata were processed. Each organ was originally recovered for 
transplantation, but subsequently discarded as deemed unsuitable for transplantation. 
 
2.2 Pancreas preparation 
Organs were received in cold sterile preservation solution after en-bloc removal that included the 
whole organ pancreas, duodenum and spleen, and then prepared by removing the duodenum and ligating 
all of the vascular branches from the arterial arcade connecting the pancreatic head with the duodenum. 
Thereafter, the pancreatic duct (PD) was cannulated with a 14G catheter. The peripancreatic fat was 
trimmed, the splenic vessels were ligated at the splenic hilum, and the spleen was removed. The superior 
mesenteric artery (SMA) and proximal stump of the splenic artery (SA) were cannulated using 16G 
plastic connectors. Pancreata were then washed with 500 ml of saline solution containing 50 ml of 
betadine and then with 10% Penn/Strep solution. They were eventually rinsed with 500ml of sterile PBS 
and stored at 4°C. 
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2.3 Pancreas decellularization 
After placing the pancreas in an ad hoc container, PD, SMA and SA were connected to a double-
line peristaltic pump (Masterflex L/S, easy load pump head and L/S 16G tubing, Cole-Parmer Instrument 
Co, Vernon Hills, IL, USA) (Fig. 1). Then, the pancreas was flushed with 4°C phosphate buffer solution 
(PBS) and heparin (1% off 1000 U, 10U/ml) at 6 ml/min for 60 minutes (360 mL total). Afterwards, 1% 
Triton X-100 and 0,1% ammonium hydroxide solution was perfused at 12.5 ml/min for 48 hours (72 L 
total) through both inlets (PD and SMA/SA inlet), at 4°C. The so-obtained hpaECMs was then rinsed 
with DNAse (D5025–Type IV, deoxyribonuclease from bovine pancreas, Sigma Aldrich, St. Louis, Mo) 
and 0.0025% magnesium chloride). Finally, scaffolds were perfused with saline at a flow of 6 mL/min for 
5 days (12.9000 L total) to remove detergent and stored at 4°C. Scaffolds destined for cell seeding 
experiments (see below) were sterilized by γ-irradiation (12.000 Gy) and stored in PBS at 4°C. Scaffolds 
destined for immunological studies were γ-irradiated, lyophilized, and stored at 4°C. 
 
2.4 Bioscaffold characterization 
2.4.1 Vessel patency 
To evaluate the patency of the hpaECMs’ innate vasculature, angiography was performed by 
injecting 5 ml of contrast agent in each inlet (PD, MSA and SA, 15 mL total) at the flow rate of 25 
mL/min. 
2.4.2 Collagen and DNA quantification 
Collagen and DNA content of fresh and decellularized pancreas was measured through indirect 
quantification of hydroxyproline residues using the Quick-Zyme Total Collagen Assay (QuicZyme, 
Biosciences), and using a tissue DNA isolation kit (PureLink Genomic DNA MiniKit, Invitrogen), 
respectively, as previously described.20 
2.4.3 Basic histology, immunofluorescence and cellularity 
hpaECMs samples were fixed for 24 hours in formalin, washed in diH2O, dehydrated in graded 
alcohol, embedded in paraffin, 5 mm-sectioned, and eventually stained with H&E, Masson’s Trichrome 
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(MT), elastic Van Gieson (EVG), Alcian Blue (AB) and Picrosirius Red (PR). Slides were compared with 
counterparts obtained from discarded pancreata that did not undergo decellularization. 
For immunofluorescence analysis, slides were incubated overnight with primary antibodies 
against collagen type I (dilution 1:25, Southern Biotech), collagen type IV (dilution 1:100, Southern 
Biotech), fibronectin (dilution 1:100, Santa Cruz), laminin (dilution 1:200, Sigma), HLA Class I (dilution 
1:100, Abcam) and HLA DP+DR+DQ (dilution 1:25, Abcam). Nuclei were counterstained with DAPI. 
Slides were visualized using fluorescence microscopy (Carl Zeiss) and compared to counterparts obtained 
from discarded pancreas that did not undergo decellularization. 
To quantify the remaining cells after decellularization, a portion of fresh and acellular tissue was 
frozen in liquid nitrogen and 10 slides of each tissue were analyzed with an optical microscope. The 
samples were covered with Vectashield (Vector Laboratories, Inc, Burlingame, CA) mounting medium 
for fluorescence with 40-6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc), and the total 
number of nuclei per field was counted in random pictures using fluorescence microscopy (Carl Zeiss). 
2.4.4 Scanning electron microscopy (SEM) 
To evaluate scaffolds’ ultrastructure, samples of hpaECMs and normal pancreas were processed 
and analyzed as previously described.20 Images were recorded with a Jeol7401 FEG scanning electron 
microscope.  
2.4.5 Chicken chorioallantoic membrane (CAM) angiogenic assay 
To assess the angiogenic properties of our scaffolds, we used the CAM assay as previously 
described.20-22 Primary endpoint was the number of blood vessels converging towards decellularized 
matrices, which were counted manually. Only blood vessels less than 10mm in diameter were counted by 
blinded assessors (n=4), with the mean of the counts being considered. 
2.4.6 Measurement of pancreatic tissue stiffness 
To assess hpaECMs stiffness, dog bone shaped samples, 4mm wide at the narrowest point with a 
length of 18mm, were punched from wet pancreas before and after the decellularization process. The 
mechanical properties were measured using tensile extension by a uniaxial load test machine 
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(Instron5544, Instron Corporation, Issaquah, WA) with an extension rate of 10.0 mm/min. Scaffold's 
stress-stain curves were recorded and Young's modulus and tensile strength and strain at break were 
obtained. Six samples were measured for each scaffold allowing the mean and standard deviation to be 
calculated. 
2.4.7 Growth factor (GF) analysis 
We hypothesized that GFs, cytokines and chemokines are only partially depleted from our 
matrices. To validate our hypothesis, we produced 5 hpaECMs from 5 different organs (study group). 
Two samples were procured from each scaffold (10 pieces total) with a 12mm biopsy punch; the control 
group consisted of 10 samples obtained in the same fashion from 5 discarded pancreata that did not 
undergo decellularization.  All samples were stored in sterile PBS with 2% pen/strep and then shipped to 
the manufacturer (Raybiotech, http://www.raybiotech.com), where they were processed using the 
Quantibody® Human Growth Factor Array Q1. 
2.4.8 Immunological studies 
a] Isolation of T cells: Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll gradient 
centrifugation of de-identified buffy coats from healthy donors purchased from the NY blood bank. Naïve 
CD4+ T cells were enriched over the auto MACS cell separator by negative selection with naïve CD4 T 
cell isolation kit (Miltenyi Biotec, Inc., Auburn, CA). After isolation, cells were stained for CD4 and 
CD45RA to confirm purity that was consistently higher than 95%. 
b] In vitro cultures: carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled T cells were activated 
with anti-CD3/anti-CD28 coated Dynabeads (Life Technologies, Grand Island, NY) with or without IL-2 
(100U/mL; BD Biosciences, San Jose, CA) and cultured alone or in the presence of lyophilized 
hpaECMs. Before use, hpaECMs was incubated at 37°C overnight and filtered through a 40 µm strainer. 
Naïve CD4+ T cells were cultured at 37 in 5% CO2 atmosphere in complete RPMI plus 10% heat–
inactivated human AB serum (regulatory T cell induction experiments were performed with 2% AB 
serum) for 5 days and then analyzed for CFSE dilution by FACS. CFSE was obtained from Invitrogen 
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(Carlsbad, CA). 
c] Antibodies, staining protocols, flow cytometry: Cell surface staining was performed using antibodies 
against CD4, CD8, and CD25 from eBioscience (San Diego, CA). Appropriate isotype matched 
monoclonal antibodies were used as controls. To evaluate cell apoptosis and death, cells were stained 
with antibodies against Annexin V and 7-AAD (BD Biosciences) in appropriate staining buffer (BD 
Biosciences). To measure the percentage of CD4+CD25+FoxP3+ cells, cells were permeabilized and 
stained with anti-FoxP3 antibody (eBioscience) according to manufacturer's instructions. Flow cytometric 
analysis was performed on a FACSCanto II flow cytometer using DiVA software package (BD, Franklin 
Lakes, NJ). Data were analyzed using CytoBank software (https://www.cytobank.org). 
 
2.5 Assessment of the ability of hpaECMs to sustain cell attachment and growth 
a] Human islets:  Pancreases were processed using standard Liberase HI collagenase digestion with 
mechanical dissociation within a Ricordi chamber. Islets were purified with an optiprep discontinuous 
gradient method, identified and counted using dithizone staining. paECMs samples were prepared as 
shown in Figure 1, sterilized via γ-irradiation and placed in RPMI with 10% FBS overnight at 4ºC, prior 
to seeding. The day after, 200 islets per scaffold were statically seeded on matrices with fresh media and 
cultured under standard conditions in RPMI media with 10% FBS for 4 days prior to perifusion testing.18 
As control, additional islets were cultured on standard Petri dishes under the same culture conditions. 
Briefly, each group of 200 islets was placed into perifusion chambers, either seeded on scaffolds or free. 
The chambers were then perifused with Krebs-Ringer-bicarbonate (KRB) solution containing 0.2% 
bovine serum albumin (BSA) at a flow rate of 0.3 mL/min. During the procedure the KRB was 
continuously gassed with 95% air/5% CO2.  The islets were pre-perifused for 1 hour in a low glucose (3.3 
mM) KRB solution prior to sampling.  After one hour, effluent samples were collected from the low-
glucose KRB solution every 5 minutes for 20 minutes.  Then a high-glucose solution (16.7 mM) was 
perifused through the chambers for 30 minutes with effluent sample collection every 2 minutes.  
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Following the 30 minutes of high glucose, the chambers were perifused again with low-glucose KRB for 
30 minutes with samples collection every 5 minutes.  The effluent samples were stored at -20°C until 
analyzed for insulin content via radioimmunoassay.  Insulin values are normalized to basal averages, n=4, 
error bars represent SEM.   
b] Human endothelial cells: Human primary pancreatic endothelial cells (hPPECs) were isolated from 
discarded pancreata as described by Navone et al.23 Cells were then expanded on matrigel–coated flasks 
and grew with endothelial proliferation medium (EndoPM). At the time of seeding, 20x106 cells were 
injected with a syringe pump in a whole acellular pancreas scaffold through the SMA and SA, at a flow of 
0.2ml/min. Cells were allowed to attach for 2 hours, after which perfusion culture started. Seeded 
matrices were cultured in a custom-built bioreactor (Fig. 8B). Media were infused through Luer lock 
access ports and allowed to equilibrate with 5%CO2 and 95% room air by insertion of 0.22μm filters and 
magnetic stirring. The system (and the related technical support) was designed and developed by SKE 
Advanced Therapies. 
After 6 days, matrices were fixed in formalin, sampled into 5-μm sections, and stained for H&E, 
CD31 (clone JC70A, 1:100, DAKO), Ki67 (clone Mib1, 1:600, DAKO) using standard protocols. 
Antigen retrieval was performed with Tris EDTA pH 9 for both antibodies. The percentage of Ki67+ cells 
was obtained as the ratio of Ki67+ and hematoxylin+ cells. Immunohistochemistry and H&E-stained 
images were recorded using Aperio Scan System (Leica Microsystems). 
 
3. Results 
3.1 Human pancreas decellularization 
Triton-based perfusion allowed complete clearance of the cellular compartment of discarded 
pancreata (Fig. 1A-B). Fluoroscopy depicted an intact vascular network that retained the hierarchical 
branching structures (Supplementary Fig. 1C-G). In fact, contrast media flowed progressively from larger 
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vessels to smaller capillaries to eventually drain out through the venous outlets, without extravasating 
within the hpaECMs. 
 
3.2 Collagen and DNA quantification 
To investigate the ability of the decellularization protocol to maintain ECM components of the 
native pancreas, fresh and acellular samples were processed for collagen quantification. Quantitative 
assay showed statistically increased collagen in acellular matrices compared to fresh tissue (from 
22.9±10.0 to 75.4±16.8 μg/mg, P<0.001). 
DNA analysis was performed as indirect proof of successful decellularization and demonstrated 
approximately 99% clearance of DNA in comparison with the native organ (from 1.35±0.43 to 0.04±0.03 
μg/mg, P<0.001) (Fig. 1H). 
 
3.3 Basic histology, immunofluorescence and cellularity 
Fresh and acellular samples were processed for Masson trichrome, Picrosirius red, elastic Van 
Gieson and Alcian blue (Fig. 2). All stainings confirmed complete absence of nuclear material and cells, 
consistent with the H&E and DAPI findings. Masson trichrome and Picrosirius red revealed preservation 
of collagen fibers. Alcian blue staining indicated preservation of sulfated glycosaminoglycan proteins. 
Elastic Van Gieson staining showed that elastin was retained after decellularization.  
DAPI and H&E staining, as well as immunofluorescence for both HLA class I and class II 
antigens confirmed the complete clearance of the cellular compartment of the hpaECMs (Fig. 3A). The 
scaffolding architecture of the pancreas was well preserved. In fact, H&E staining showed the pink 
eosinophilic staining typical of collagen in the absence of any basophilic staining indicative of cellular 
nuclear material (Fig. 2). Specific nuclei staining with DAPI confirmed the absence of cell nuclei after 
decellularization; this finding was also supported by the count of the total number of nuclei per field in 
random pictures (from 410±120 to 0 nuclei, P<0.001). As an indirect sign of successful decellularization, 
neither HLA class I or class II positive cells were seen in the pancreatic matrices. 
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Immunofluorescence for specific ECM molecules that have a significant role in the pancreatic 
parenchyma was performed for a fuller characterization of our scaffolds. Immunostaining detected the 
presence of laminin, collagen I, collagen IV and fibronectin in the native pancreas (Fig. 3B). Laminin 
detection in the acellular matrix showed strong positivity similar to fresh tissue, especially around vessels 
and structures resembling the native sites of the islets. In contrast, preservation of collagen I (Fig. 3B) was 
less evident with respect to the fresh pancreatic ECM, while immunofluorescence for collagen IV and 
fibronectin Fig. 3C) showed specific distribution of both components at the same level of native tissue. 
 
3.4 Scanning Electron Microscopy (SEM) analysis 
SEM revealed retained nanofibrous structures in hpaECMs and confirmed absence of intact cells, 
suggesting that the decellularization process produced an acellular matrix scaffold that retained the micro- 
and ultra-structural details of pancreas architecture (Fig. 4). 
 
3.5 CAM assay 
To test the ability of hpaECMs to induce neo-angiogenesis, samples of matrix were implanted in 
ovo. CAM assay showed that the scaffolds integrated well with the developing environment of the 
chicken egg and representative images of the implanted scaffolds at 0 and 7 days of incubation 
demonstrated generation of capillaries around and above the scaffolds (Supplemtary Figure 1, top). 
Neoangiogenesis was quantified by manually counting the total number of blood vessels converging 
towards matrices. Seven days after implantation, the number of vessels growing towards the acellular 
scaffolds was significantly increased in comparison to the same sample at day 0 (P<0.05) and to the filter 
membrane loaded with PBS that was used as a negative control (P<0.05) (Supplementary Fig. 1, bottom). 
Interestingly, the pro-angiogenic effect of hpaECMs was comparable with VEGF-loaded membrane used 
as positive control (P>0.05). 
 
3.6 Acellular scaffold stiffness properties 
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It has been proposed that the ECM has the ability to maintain the original mechanical properties 
of native organs. By assessing the mechanical properties of our scaffolds, we were able to partially 
elucidate the influence of the decellularization process on ECM in terms of destruction, degradation 
and/or decomposition. The properties of native pancreas were compared with that of hpaECMs. The 
results showed that the Young's modules and tensile strain at break had slight decreases, but no significant 
difference after the removal of cellular components, changing from 0.165±0.039 MPa and 96.71±39.67% 
to 0.139±0.052 MPa and 76.22±22.23% respectively (Supplementary Fig. 2). The tensile stress at break 
of decellularized pancreata (0.070±0.017MPa) was comparable to the native pancreas (0.068±0.006MPa) 
(P<0.05). These results indicated that the ECM plays a prominent role in determining the mechanical 
properties of the pancreas, and that our decellularization method effectively maintains the integrity of the 
tissue's ECM without destruction or degradation. 
 
3.7 hpaECMs retain GFs 
Data obtained from the quantitative array platform showed that several GFs were still present in 
the hpaECMs after decellularization. Some of these molecules are essential in angiogenesis and 
vasculogenesis, cell development, neuronal growth and regeneration, as well as insulin level and glucose 
homeostasis (Supplementary Table 1). Intriguingly, hpaECMs also contains TGF-β1, a cytokine with 
immune modulating effects [4]. 
 
3.8 hpaECMs immune effects 
a] hpaECMs inhibits naïve CD4+ T cell expansion: To test effects of hpaECMs on human naïve CD4+ T-
cell function, we stimulated CFSE-labeled naïve CD4+ T cells with anti-CD3/anti-CD28 mAbs in the 
presence or absence of hpaECMs and quantified proliferation by CFSE dilution using flow cytometry. 
These assays showed a statistically significant inhibitory effect of hpaECMs on naïve CD4+ T cell 
proliferation (Fig. 5A-B).  
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b] hpaECMs induces T cell apoptosis: To investigate whether hpaECMs inhibitory effects on T cell 
proliferation was associated with T cell apoptosis, we activated T cells with anti-CD3/anti-CD28 and we 
cultured them with or without hpaECMs. On day 5 of culture, we stained cells for Annexin V and 7-AAD 
and found a significant increase in cell apoptosis/necrosis when cells were cultured in the presence of 
hapECMs (Fig. 5C-D).  
c] hpaECMs induces conversion of naïve CD4+ T cells into regulatory T cells (Treg): Through their 
capacity of inhibiting effector T cell expansion and function, Treg are essential for immune homeostasis 
and are critical for tolerance induction and maintenance in organ transplantation.24 There are two major 
subsets of CD4+ Treg: thymus-derived CD4+CD25+Foxp3+ Treg and inducible Treg that develop from 
naïve T cells in the periphery under tolerogenic conditions.  
Since TGF- is crucial for Treg induction and ECM contains TGF-, we hypothesized that ECM 
promoted conversion of naïve CD4+ T cells into Treg. To test this hypothesis, we performed in vitro Treg 
induction assays by stimulating naïve CD4+ T cells with anti-CD3/anti-CD28 mAbs, IL-2, with or without 
hpaECMs. The presence of hpaECMs significantly increased the percentage of CD4+CD25+FoxP3+ Treg 
at the end of the culture (Fig. 5E-F).  
 
3.9 Cell Seeding of acellular pancreatic scaffold 
a] Human Islets: Islets stained positive for DTZ on both scaffolding (Fig. 6D) and culture dishes (Fig. 
6C).  Both islets seeded on scaffolds and islets on culture dishes were functional following 4 days of 
culture with similar stimulation indices (as defined as the peak insulin secretion rate divided by the basal 
insulin secretion rate) of 2.81±0.48 and 3.44±1.821 respectively (p=0.59, average ± standard deviation, 
n=3) (Fig. 6E). These data clearly demonstrate that the decellularized scaffold did not cause any toxicity 
to the islet cells seeded on it. 
 
b] Human endothelial cells: hapECM was seeded with human pancreatic endothelial cells. Pancreatic tail 
was surgically isolated in order to obtain a smaller volume to seed, keeping at the same time an inflow 
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and an outflow (Fig. 7A). Matrix was seeded with cells and cultured for six days in a bioreactor, 
consisting in a closed circuit with one chamber for organ housing, a reservoir for medium oxygenation 
and a peristaltic pump (Fig. 7B). At H&E, cells were ubiquitous within the matrices, yet tended to 
localize at the level of small and large vessels. Cells distributed in a line on the edges of the vessel walls 
resembling primitive structures of vessel formation (Fig. 7C). All cells confirmed their endothelial nature 
as evidenced by CD31 staining. More than 50% of cells were proliferating, as determined by Ki67 
staining, demonstrating that a mid-term culture in the acellular scaffold allows cell survival and 
proliferation (Fig. 7D).  
 
4. Discussion 
This study represents a progression from previous work that we performed in the porcine 
pancreas, which supported our hypothesis that ECM scaffolds generated from native pancreas tissue can 
serve as a platform for insulin-producing bioengineered tissue.4,18,25 The importance of transitioning to 
human organs is obvious in the context of clinical relevance. Our results indicate that whole discarded 
human pancreata can be consistently and successfully decellularized through detergent-based perfusion 
methodology. Indeed, clearance of cells and HLA class I and II antigens is achieved despite preservation 
of the ECM’s architecture, composition and mechanical properties.  In addition, the framework of the 
vascular network remains intact at all hierarchical levels. Interestingly, for the first time we report that 
numerous GFs are retained in significant amounts within the 3D structure of our hpaECMs. Some of these 
GFs are key players in essential pathways such as angiogenesis, cell proliferation and glucose 
metabolism, and their presence may justify the scaffold’s ability to induce angiogenesis in the CAM 
assay. Importantly, we documented that hpaECMs inhibits naïve CD4+ T cell proliferation, promotes their 
apoptosis, and induces their conversion into Tregs.26 
Our data obtained with discarded human pancreas are consistent with our previous experience 
with discarded human kidneys.20 However, in contrast to that experience, we used Triton rather than the 
more aggressive SDS for two reasons: first, because the pancreas texture is less dense then the kidney’s, 
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which is basically refractory to nonionic detergents such as Triton; second, we believe that pancreatic 
enzymes released during cell breakdown occurring during the decellularization process can, in turn, 
contribute to further clearance of the cellular compartment. Moreover, our study builds on our preliminary 
experiments with the porcine pancreas,18 in which we subjected the organs to a 24-hour cycle of 
decellularization with Triton-based solution.  Nevertheless, in the case of discarded pancreata, we used a 
48-hour decellularization cycle – twice the length – that was infused through three different inlets (PD, 
SMA and SA), rather than just two, namely the PD and the superior mesenteric vein. We did so following 
initial unsuccessful attempts while using only the original two inlets, 24-hour approach, in which we 
observed a frank impairment of the decellularization process possibly attributable to the significant tissue 
damage that had justified discard. Overall, we hypothesized that the 3-inlet approach – namely, PD, SMA 
and SA – would be crucial to successful decellularization, as it would allow ad hoc delivery of the 
detergent throughout the whole pancreas; and that the higher volume would possibly circumvent hurdles 
deriving from organ damage such as steatosis and fibrosis.  
Previous studies reported immunomodulatory properties of the innate ECM in rodents.27-30 Our 
studies for the first time document the immunosuppressive, Treg-promoting properties of our hpaECMs. 
Though further studies are needed to understand the mechanisms of the immune properties of our 
matrices, these effects can be – at least in part – attributed to the presence of TGF- within the matrix that 
may induce T cell apoptosis and promote conversion of naïve CD4+ T cells into CD4+CD25+FoP3+ 
Treg.26 As we did not investigate whether SDS remains in our acellular scaffolds, we cannot formally rule 
out the possibility that hpaECMs-induced T cell apoptosis is related to the presence of residues of 
detergent used for decellularization. However, the effect of our matrix on Treg induction and – more 
importantly – the evidence that both islets and endothelial cells are well viable and functional when 
seeded on hpaECMs, make this option unlikely. Altogether, these important data support the use of 
hpaECMs as a matrix to generate bioengineered pancreases and pave the way to further studies on the 
therapeutic use of hpaECMs as immunosuppressant.  
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In order to assess hpaECMs cytocompatibility, we used islets and a unique endothelial cell line 
isolated from the human pancreas, namely hPPECs.  In both cases, findings show that our matrices are 
both islet- and cell-friendly, as they allow attachment, function and maintain the initial phenotype. In the 
attempt to assess cytocompatibility, while the choice of islets is obvious, hPPECs are justified because we 
envision that when this technology is successfully translated into the clinic, the first step to follow the 
production of hpaECMs will be the reconstitution of the endothelium starting from patient’s own 
endothelial cells. In line with our experience with renal ECM scaffolds produced from discarded kidneys, 
it is important to emphasize that the strategy of using discarded organs introduces a new type of 
biomaterial, represented by natural scaffolds obtained from the manipulation of organs with pre-existing 
damage.  
Whether hpaECMs will represent a genuine platform for organ bioengineering investigations, still 
needs to be confirmed, but early results are encouraging and pave the way for further investigations 
aiming at understanding the mechanisms of interactions between the matrix and the cells, and at 
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Figure 1. Decellularization process, fluoroscopy and DNA quantitation. Panels A and B show the set-up 
of the core for organ decellularization in a discarded human pancreas before and after the treatment. Red 
arrows in the first image show the arterial, represented by superior mesenteric artery (SMA) and splenic 
artery (SA) that share one of the two detergent inflows. Green arrow indicates the second inflow through 
the pancreatic duct (PD). Notably, during decellularization, the color of the organ macroscopically 
changed from a golden brown color to straw yellow but without reaching the whitish color described for 
porcine pancreas scaffolds [20]. Fluoroscopy of hpaECMs performed through SMA (Panel C), SA (panel 
D) and PD (panel E, F, G). Contrast media flows within the framework of the innate vasculature of 
hpaECMs without extravasation. Panel H confirms satisfactory cell and DNA clearance. Statistic was 
made by t-test of fresh vs. acellular tissue; *** p0.001. 
Figure 2. Basic histology of hpaECMs as compared to the native pancreas. H&E demonstrates complete 
loss of cellular elements with preservation the intercellular framework. The larger empty spaces on the 
left aspect of the section almost certainly reflect pathological lesions the nature of which cannot be 
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ascertained with confidence without having examined the sections before treatment, although one can 
speculate that they represent focal fat necrosis.  
Masson trichrome shows the light green ECM framework. On the left aspect of the right panel there is 
evidence of scarring indicated by the dense area staining green. 
Alcian blue demonstrates preservation of the so-called ground substance in the connective tissue 
framework, although the process of digestion involved in decellularization has altered the faint blue color 
of Alcian blue into a faint green color as can be seen in the right panel.  
The van Gieson stain demonstrates preservation of elastine. 
The picrosirius red demonstrates abundant collagen in the right panel, reflecting significant scarring in the 
field photographed in contrast to the left panel. 
Figure 3. Immunohistochemistry. Aside of nuclear staining, presence of possible immunogens was ruled 
out by immunostaining for major histocompatibility complex of class I and II (HLA I and II). 
Immunostaining for critical, ubiquitous components of pancreas ECM showed that laminin, fibronectin, 
collagen type I and IV remains well preserved in hpaECMs (nuclei were conterstained with DAPI) and 
displays a similar distribution of these proteins in the fresh and decellularized pancreas bioscaffold 
sections. 
Figure 4. SEM of intact and acellular pancreas ECM. A. Low power magnification of a cross section 
through the decellularized pancreas demonstrating preservation of the ECM supporting the exocrine and 
endocrine elements as well as the vasculature. B. Three dimensional view of the ECM framework of an 
islet of Langerhans in the decellularized pancreas, identifiable by what is presumably its spherical 
microvascular framework.  C. Cross-section through what we interpret as an arteriole with the lumen 
delimited by the internal elastic membrane and external to it the individual layers of basement membrane 
of dissolved smooth muscle fibers of the arteriole’s media. D. A presumed venule identifiable by the 
smaller number of layers of smooth muscle cells (identified by the layers of basement membrane) 
forming its wall and two small tributaries presumed to be contributing to its formation.  
Peloso et al. Discarded Human Pancreas Page 22 
 
Figure 5. Immune properties of hpaECM. (A)  Representative plots and (B) quantitation of CFSE dilution 
in CFSE-labeled human naïve CD4+ T cells stimulated with anti-CD3/anti-CD28 coated beads cultured 
with or without hpaECM. (C) Representative plots and (D) quantitation of Annexin-V and 7-AAD 
expression as a measure of apoptosis/necrosis in human naïve CD4+ T cells stimulated with anti-
CD3/anti-CD28 coated beads cultured with or without hpaECM. (E) Representative plots and (F) 
quantitation of FoxP3 expression in CD4+CD25+ cells converted from human naïve CD4+ T cells 
stimulated with anti-CD3/anti-CD28 coated beads and IL2 cultured with or without hpaECM. All 
experiments were analyzed on day 5. Data are means+SD; four experiments). *P<0.05. 
Figure 6. Evaluation of islets seeded onto decellularized scaffolds. (A) Decellularized scaffolds prior to 
seeding. (B) Scaffold immediately after seeding, black arrows indicate islets. (C) Dithizone stained islets 
after 4 days in culture on culture plates.  (D) Dithizone stained islet located on periphery of scaffold, 4 
days after seeding onto scaffolds. (E) Glucose stimulation index (GSI) for human islets after 4 days in 
culture. In order to determine the functionality of islets following 4 days of culture dynamic perifusion 
tests were conducted. 200 islets were placed into perifusion chambers, either seeded on scaffolds or free. 
The chambers were then perfiused with Krebs-Ringer-bicarbonate (KRB) solution containing 0.2% 
bovine serum albumin (BSA) and either 3.3 mM or 16.7 mM glucose at a flow rate of 0.3 mL/min with 
continuous gassing with 95% air/5% CO2 and effluent sample collection. The effluent samples were 
stored at -20°C until analyzed for insulin content by radioimmunoassay. The glucose stimulation index 
defined as the ratio of insulin secreted during the high glucose period normalized to the insulin secreted 
during the basal glucose period was then calculated.  Both islets in standard culture conditions as well as 
islets seeded on scaffold demonstrated similar responses to changes in glucose concentration. Data 
represent mean + standard deviation, n=3. TCP denotes tissue culture plate. 
Figure 7. Endothelial cell seeding. Matrix was seeded with human pancreatic endothelial cells and 
cultured for six days in a bioreactor, consisting in a closed circuit with one chamber for organ housing, a 
reservoir for medium oxygenation and a peristaltic pump (Ismatec), connected by tubing (ID 1/16", 
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Pharmed BPT) Pancreatic tail was surgically isolated in order to obtain a smaller volume to seed keeping 
at the same time an inflow (SA – red connector) and an outflow (Splenic Vein -SV- blue connector) 
(Panel A). Panel B indicates a schematic representation of the perfusion circuit for seeded pancreatic 
scaffold culture. Panel C shows a representative image of H&E stain showing localization of infused cells 
in vessels. Boxes indicate areas reported with high magnification in the panel below. Panel D illustrates 
representative images of H&E (left), CD31 (middle) and Ki67 (right) matrix staining. 
Supplementary Figure 1. CAM assay. CAM assay showed that, after seven days of implantation, the 
number of vessels converting towards the decellularized pancreas significantly increased in comparison to 
the same samples at day 0, and the negative control. 
Supplementary Figure 2. Mechanical properties of hpaECMs. Graph on mechanical properties show 
similar patterns between native pancreata (non treated) and hpaECM for tensile strain. Table below 
indicates data related to modulus (expressed in MPa), tensile strain at break (%) and tensile stress at break 
(%).  
 
